1st half day 2nd half day dash 1st half month 2nd half month dash 1st digit year 2nd digit year 3rd digit year last digit year
Propecia Could Be Challenged By New Research

Written by Stuart Stevens | Monday, 11 December 2006

For now men who are suffering from Male Pattern Baldness will find that the best thing that they can do about the problem is to get a prescription for Propecia. Propecia that is made by the drug company Merck is statistically the most effective medicine for the condition that sees some men as young as 20 start to lose hair gradually over the course of their lives. Propecia is not 100% effective, but independent research shows that it can help as many as 90% of men and some will even experience regrowth of hair as well as the discontinuation of hair loss.

In the future things could change as much research is being done on gene therapy to limit male pattern baldness and if this research proves positive and the outcome is a viable commercial treatment that beats MPB at the molecular level then it could have a big effect on the sales of the hair loss drug Propecia.

Recent research done in Russia on a group of people who were noted to experience high levels of hair loss has identified faulty genes that could be the trigger for hair loss and thus if a treatment is made to rectify this problem at the root the sales would be huge and male pattern baldness could become a thing of the past.

Until then Propecia remains the best way forward for men to deal with their hair loss as it prevents the formation of dihydrotestosterone in the man’s scalp, which is reason why the hair falls out. Propecia is now used by millions of men worldwide and sales are still growing for its company Merck. Propecia is also popular because it the first serious hair loss treatment that does not involve rubbing lotions and tonics on the scalp and is just administered daily by swallowing a small pill.

© 2008 This content has been exclusively written by UKMedix
Goto ChatterBack with UKMedix
ChatterBack with UKMedix

There are 0 comments on this article.

Place a comment now scroll down
Name :  *
Comment :  *
 
Code :  * (please enter the code above)
 

Fields marked with  * are required.